York Bioanalytical Solutions Limited

York Bioanalytical Solutions Ltd, based in Upper Poppleton, York, UK, is a large, holding company with an active status. Founded 25 years ago in 1999, it employs 68 people and boasts £17,224,642 in assets, generating £7,924,181 in yearly revenue. The company has a real address and is overseen by four directors and one owner, maintaining a stellar 5.0 Google rating from five reviews. It regularly imports miscellaneous chemical products (34 months) and occasionally exports plastics and plastic products (1 month).

The company’s website reveals it’s a specialist provider of bioanalytical, metabolism, and biomarker services to pharmaceutical and biotech companies. It offers services ranging from discovery to post-marketing, including bioanalysis, in vitro ADME, metabolism, and biomarker development. It’s clear they’re focused on high-value, technical services rather than direct retail. They even have a presence at conferences, like the European Bioanalysis Forum.

Financially, York Bioanalytical Solutions Ltd presents a mixed picture. While cash bank holdings increased by a substantial 31% to £12 million, net assets also rose by 12% to £22 million. However, administrative expenses increased significantly, jumping 46% to £2.7 million. Debtor’s have increased by 42% to £2.4 million, which may indicate a growing business but also a risk of delayed payments. Bank borrowings have decreased by 15% to £1.2 million. The company’s large size (meeting two of three conditions for a large company) suggests it’s well-established, but the increased expenses warrant closer monitoring. The company’s auditor, Azets Audit Services Limited, has performed the audit. The financial statements are unaudited, and the company is not required to publish detailed profit and loss statements.

Registered in England/Wales under the registration number 03776816, with a registered address at YO26 6QR, Upper Poppleton York, North Yorkshire, Cedar House Northminster, Business Park Northfield Lane.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.